
Mineralys shares climb on study data for blood pressure drug
An experimental drug from Mineralys Therapeutics succeeded in a pair of trials in people with stubbornly high blood pressure, the biotechnology company said Monday. Mineralys has been developing the drug, dubbed lorundrostat, in people whose high blood …